Conditions associated with MCAS include: Chronic Lyme disease Fibromyalgia Autism Hypercoagulation ME/CFS (chronic fatigue syndrome) Irritable bowel syndrome (IBS) and small intestine bacterial overgrowth (SIBO) POTS/Dysautonomia Hypermobile Ehlers-Danlos syndrome Multiple chemical sensitivity Autoimmune conditions Mast Cell Activation Syndrome in Digestive Disorders Mast cells are highly concentrated in the gastrointestinal tract to protect humans from any foreign invaders they may swallow
prolactin within normal range or hyperprolactinemia
Hormones: Overview and Types compensatory TSH Orbitopathy and myxedema Myxedema A condition characterized by a dry, waxy type of swelling (edema) with abnormal deposits of mucopolysaccharides in the skin and other tissues
As with any medication, there are potential side effects, including nausea, constipation, and diarrhea
Growth in Gene and Cell Therapy Trials According to the American Society of Gene & Cell Therapy (ASGCT)-Citeline Q1 2025 report, the combined gene, cell and RNA therapy pipeline featured 4,418 active programs, including 2,155 gene therapies and 966 non-genetically modified cell therapies with 79 new gene therapy trials (57% in oncology) and 27 new cell therapy trials (74% in non-oncology) initiated that quarter
IGF-1 elevation from full HGH use is associated with increased cell proliferation risk, fluid retention, and carpal tunnel syndrome at therapeutic doses
